LIM domain kinases (LIMKs), which modulate cytoskeletal dynamics, are found throughout the central nervous system. The synaptic junctions between neurons show structural alteration or plasticity during neurodevelopment, learning and memory formation, or after injury and disease; in some cases completely new connections form, while others are lost. This remodeling is under the control of the actin cytoskeleton and therefore is influenced by the activity of LIMKs (Scott and Olson, 2007) . Recent reports discussed in this perspective shed light on the potential role of LIMK in hippocampal dendritic spines and photoreceptor presynaptic terminals and illustrate the importance of LIMK in nerve cell function.
density and insufficient LTP coupled with reduced phosphorylation of LIMK1 and cofilin and reduced actin polymerization in cortex and hippocampus (Wang et al., 2018) . PAK2 +/mice also exhibit various autism-related behaviors. Consistent with these results, the authors found that PAK2 damaging mutations were significantly enriched in patients with autism-spectrum disorder.
Finally, deletion of the LIMK1 gene is associated with Williams-syndrome, a disease in which individuals are characterized by preserved short-term memory but heavily impaired visuospatial construction and LTM. Todorovski et al. (2015) created LIMK1 -/and LIMK1 +/-KO mice which exhibit features similar to humans suffering from Williams-syndrome: heavily impacted LTM with intact short-term memory. In these mice the L-LTP was impaired, but the early-phase long term potentiation (E-LTP) was unaltered. Although mechanisms for L-LTP are thought to be the attributed to synaptic mechanisms for LTM suggesting a role for LIMK in the formation of LTM, Todorovski et al. (2015) also provided evidence that LIMK might regulate L-LTP via a cofilin-independent pathway. Cyclic AMP response element-binding protein (CREB) is crucial for LTP and LTM, but not for E-LTP or short-term memory. They showed that LIMK1 is expressed and colocalized together with CREB in hippocampal neurons, and that plasticity-dependent activation of CREB is reduced in LIMK deficient mouse models. In line with this, manipulation of CREB itself, without cofilin, was enough to restore L-LTP and LTM in these animals supporting the cofilin independent pathway hypothesis. It is not clear how synaptic plasticity leads to LIMK1-mediated CREB activation. One plausible explanation is that activated LIMK in the spine translocates to the nucleus, where it binds to and activates CREB. Other possible scenarios are that LIMK might activate CREB via activating protein kinase C or mitogen-activated protein kinase (Todorovski et al., 2015) .
A focus on microRNAs has led to an unusual therapeutic approach to LIMK-associated brain disease. MicroRNAs are small, endogenously expressed noncoding RNAs which regulate the expression of other RNAs by interacting with them. Elevated levels of miRNA134 have been found in the dendrites of hippocampal neurons in epileptic rats (Sun et al., 2017) and in a rodent model of ischemic stroke (Liu et al., 2017) . miRNA134 is suspected to negatively regulate LIMK activation. This hypothesis is supported by the findings of Sun et al. (2017) , where overexpression of miRNA134 in in vitro and in vivo status epilepticus models resulted in decreased LIMK RNA and protein levels. Additionally, the group reported that miRNA134 directly binds to the 3′ untranslated region of LIMK RNA. Moreover, by using Ant 134, a miRNA134 antagomir, the miRNA134 effects on LIMK and cofilin expression were reversed (Sun et al., 2017) . In rat ischemic stroke, two weeks after middle cerebral artery occlusion, lesions on MRI are still present with minimal spontaneous recovery. In histological sections, the density of dendritic spines and number of synapses in hippocampal CA1 pyramidal cells are decreased. Western blots from these samples showed increased miRNA134 expression and diminished total and p-LIMK levels, indicating the connection between the two participants. In this experiment the effect of miRNA134 was ameliorated by electroacupuncture, suggesting that electroacupuncture blocks miRNA134 and might have therapeutic potential (Liu et al., 2017) . Taken together, miRNA134 inhibition via electroacupuncture or a miRNA134 blocker has potential to alter LIMK1 signaling and restore synaptic function.
Retinal plasticity: Retina, as part of the central nervous system, also exhibits synaptic plasticity. Activity-dependent changes occur in the shape of the photoreceptor presynaptic terminal and in the composition of AMPA-type glutamate receptors in the inner retina; injury-or disease-induced changes include photoreceptor axonal retraction and sprouting (Lewis et al., 1998) and photoreceptor-induced glutamate receptor loss in postsynaptic bipolar cells followed by subsequent structural remodeling (Dunn, 2015) .
The influence of LIMK in photoreceptor injury-induced structural remodeling is particular clear. While studying retinal detachment, Wang and Townes-Anderson (2015) observed that the active form of LIMK, phosphorylated-LIMK, which is present in photoreceptor terminals, increased after detachment in salamander. Others had previously shown that dramatic synaptic changes occur in rod cells after detachment (Lewis et al., 1998) and thus it was posited that activated LIMK plays a role in photoreceptor terminal plasticity. Isolated rod photoreceptors in culture exhibit axon retraction, followed by process growth at the basal (axon-bearing) region of the rod cells. Inhibition of LIMK's direct regulators, ROCK or PAK, reduced axon terminal retraction (Wang and Townes-Anderson, 2015) . These results were consistent with the function of LIMK in regulating actin rearrangement. Direct inhibition of LIMK, by a pharmacological agent, also reduced structural changes in the rod photoreceptor axon terminal (Figure 1B) . ROCK, PAK and LIMK inhibition also prevented the axonal sprouting, which is seen after surgical reattachment of the retina. Using a barbed-end assay to assess actin depolymerization and turnover, increased actin cytoskeleton rearrangement was observed in the axonal region after injury. Inhibition of ROCK or LIMK blocked such rearrangement and appeared to stabilize the actin filamentous network and thereby stabilize the presynaptic terminal (Wang et al., 2019) .
The therapeutic potential of LIMK inhibition for the retina is due to the fact that such inhibition may preserve the photoreceptor-to-bipolar synapse. This is the first synapse in the visual pathway and without it there is no vision. Thus, preventing axon retraction, which results in synaptic disjunction, and axonal sprouting, which disrupts the neural circuitry, may preserve vision after injury. This potential has been tested in the pig retina, which is a good model of human retina because of numerous similarities in structure and function. In pig retina, levels of phosphorylated cofilin, the downstream effector of LIMK, increased dramatically after retinal detachment, presumably promoted by LIMK activity. Inhibition of ROCK or LIMK reduced p-cofilin in the injured retina and significantly reduced axon retraction and thus synaptic disjunction (Wang and Townes-Anderson, 2015; Wang et al., 2019) . Inhibition of LIMK therefore is suggested to stabilize the retinal circuitry following injury. A recent study demonstrated that inhibition of the ROCK/LIMK/cofilin pathway also improved functional visual recovery after retinal detachment .
Synaptopathy, the dysfunction of synapses, is increasingly invoked as a cause for neurological disease. Autism-spectrum disorder, epilepsy, schizophrenia, Alzheimer's disease, Williams-Beuren syndrome, retinitis pigmentosa, have all shown synaptic disjunction or malfunction as part of their pathology. Injuries such as retinal detachment (described above), prolonged noise exposure, and traumatic brain injury also result in synaptic disjunction. Improved understanding of the role of LIMKs in normal and pathological synaptic plasticity may contribute to future therapies aimed to improve and preserve nervous system function.
In summary, LIMKs are present in all neurons that have so far been examined for it. They contribute to the structural changes which occur in dendritic spines with learning and memory as well as in morphological changes in synapses associated with injury and disease such as the axon retraction of rod cells. LIMKs are located downstream in the RhoA-ROCK pathway, a signaling pathway essential to control of the actin cytoskeleton. Although ROCK is a well-investigated target in neurodegenerative disease, LIMK has fewer substrates and thus controlling LIMK activity might result in positive effects similar to ROCK inhibition, but with potentially better efficacy and fewer side effects.
